Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
March 04, 2024 09:09 ET | Endonovo Therapeutics, Inc.
US Army Medical Research and Development Command Vendor Day Los Angeles, CA, March 04, 2024 (GLOBE NEWSWIRE) -- SofPulse Inc. -- a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed...
Endonovo Launches SofPulse® into the Veterans Administration
May 02, 2023 09:03 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, May 02, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) a US-based biotechnology developer, today announced the launch of SofPulse® with Academy Medical, Inc., a...
Endonovo Announces Distribution Agreement with Academy Medical
March 06, 2023 09:07 ET | Endonovo Therapeutics, Inc.
Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a...